ApiFix received Therapeutic Goods Administration certification through its distributor, Orthotech, to market the ApiFix system in Australia to treat Adolescent Idiopathic Scoliosis.
The minimally invasive ApiFix system represents a non-fusion scoliosis treatment that is designed to maintain spinal flexibility and reduce hospitalization and OR time. The company also has CE Mark approval and markets the product in Germany, Greece, Israel, Italy, the Netherlands and most recently, Spain.
ApiFix received Therapeutic Goods Administration certification through its distributor, Orthotech, to market the ApiFix system in Australia to treat Adolescent Idiopathic Scoliosis.
The minimally invasive ApiFix system represents a non-fusion scoliosis treatment that is designed to maintain spinal flexibility and reduce hospitalization and OR...
ApiFix received Therapeutic Goods Administration certification through its distributor, Orthotech, to market the ApiFix system in Australia to treat Adolescent Idiopathic Scoliosis.
The minimally invasive ApiFix system represents a non-fusion scoliosis treatment that is designed to maintain spinal flexibility and reduce hospitalization and OR time. The company also has CE Mark approval and markets the product in Germany, Greece, Israel, Italy, the Netherlands and most recently, Spain.
Copy to clipboard 
